CHEST

CHEST 2021: Study shows vaping raises the odds of developing asthma and COPD, especially in older adults, women, and Hispanic persons.

In patients with severe asthma dependent on OCS, dupilumab reduced OCS dose and improved the odds of no longer requiring OCS, suggests research presented at CHEST 2021.

CHEST 2021: Patients with severe asthma who received tezepelumab compared with placebo demonstrated rapid improvement in morning and evening peak expiratory flow.

Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."

New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.

In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.

COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.

The best asthma care is not good enough if the patient is nonadherent. Applied "humanomics" as an approach to chronic care was discussed this week at CHEST 2015.

Exacerbations of COPD often complicate CV outcomes. Two studies presented at CHEST 2015 looked at ways to refine risk factors for CV decline.

Severe refractory asthma resists conventional therapies, but a roster of new biologics, discussed at CHEST 2015 in Montreal, may soon offer relief.

Study results revealed at CHEST 2015 showed use of FeNO to assess inflammation led family physicians to change steroid dose in 50% of asthma patients.

ACOS is often first suspected in the primary care setting. Experts at CHEST 2015 reviewed the syndrome, who is at risk, and treatment challenges.

Aging and comorbidities make asthma management in the elderly much more difficult than in younger people. Get a quick look here at what to watch out for.